- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06372756
Deep Learning Reconstruction Algorithms in Dual Low-dose CTA
April 16, 2024 updated by: Hao Tang
Evaluation of Deep Learning Reconstruction Algorithms in Dual Low-dose CT Vascular Imaging
The goal of this observational study is to evaluate the impact of deep learning image reconstruction on the image quality and diagnostic performance of double low-dose CTA.
The main question it aims to answer is to explore the feasibility of deep learning image reconstruction in double low-dose CTA.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
- The raw data from patients who underwent head and neck CTA, coronary CTA, and abdominal CTA in both standard dose and double low-dose groups were included.
- Techniques such as filtered back projection, iterative reconstruction, and deep learning reconstruction were performed.
- The feasibility of deep learning reconstruction in double low-dose CTA was evaluated based on image quality and diagnostic performance.
Study Type
Observational
Enrollment (Estimated)
1200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Youfa M Tang, Doctor
- Phone Number: 8613554101223
- Email: 1525573397@qq.com
Study Contact Backup
- Name: Tan, Doctor
- Phone Number: 86 159 2631 4149
- Email: 1655118783@qq.com
Study Locations
-
-
Hubei
-
Wuhan, Hubei, China, 430000
- Recruiting
- Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
-
Contact:
- Youfa M Tang
- Phone Number: +8613554101223
- Email: 1525573397@qq.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Healthy or diseased adults undergoing CT vascular imaging
Description
Inclusion Criteria:
- Patients with head and neck CTA, coronary artery CTA, and abdominal CTA due to stroke, coronary heart disease and abdominal inflammatory disease, and abdominal tumors.
Exclusion Criteria:
- Age <18 years, pregnancy, allergic reaction to iodine contrast agent, renal insufficiency, and severe hyperthyroidism.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Standard dose group
Raw data from 400 patients with conventional dose head and neck CTA, coronary CTA, and abdominal CTA were included.
Filtered back-projection, iteration, and deep learning reconstruction were performed.
To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with conventional dose CTA.
|
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years.
It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
|
|
Double low dose group
Raw data from 800 patients with low tube voltage and contrast medium head and neck CTA, coronary CTA, and abdominal CTA were included.
Filtered back-projection, iteration, and deep learning reconstruction were performed.
To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with double-low-dose CTA.
|
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years.
It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The specificity and sensitivity calculated through the optimal cutoff value of the receiver operating characteristic curve.
Time Frame: 2026.1
|
The specificity and sensitivity were calculated separately for the standard dose group and the double low-dose group using the optimal cutoff value from the receiver operating characteristic curve, for the purpose of comparing diagnostic accuracy between the two groups.
|
2026.1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The signal-to-noise ratio calculated from image CT values and noise
Time Frame: 2026.1
|
The signal-to-noise ratio was calculated separately for the standard dose group and the double low-dose group using image CT values and noise, to assess the image quality between the two groups.
|
2026.1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Hao Tang, Doctor, Tongji Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2023
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
March 1, 2026
Study Registration Dates
First Submitted
April 11, 2024
First Submitted That Met QC Criteria
April 16, 2024
First Posted (Actual)
April 18, 2024
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 102122
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
To protect the participant privacy, the relevant data is not shared until the participants' consent
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Learning
-
Qianfoshan HospitalNot yet recruiting
-
National Taiwan University HospitalRecruitingDeep Learning | Nursing | Mechine Learning | Artificial Intelligence (AI)Taiwan
-
Democritus University of ThraceUniversity of ThessalyCompletedDeep Learning | BlinkingGreece
-
DeepMedsWithdrawnArtificial Intelligence | Deep Learning
-
RenJi HospitalNot yet recruitingApplication of Artificial Intelligence Deep Learning Technology in Magnetic Resonance Lumbar ImagingDeep Learning,Lumbar Magnetic Resonance Imaging
-
Peking University People's HospitalNot yet recruitingUltrasound | Deep Learning | Anterior Talofibular LigamentChina
-
Peking University People's HospitalActive, not recruitingUltrasound | Deep Learning | Anterior Talofibular LigamentChina
-
Hai LvActive, not recruitingFacet Joints; Degeneration ; Deep Learning ;Artificial IntelligenceChina
-
Zhujiang HospitalEnrolling by invitationLaparoscopic Surgery | Deep Learning | Artificial Intelligence (AI)China
-
Royal North Shore HospitalRecruitingArtificial Intelligence | Deep Learning | Radiation Therapy | Segmentation | ContouringAustralia
Clinical Trials on Deep learning image reconstruction
-
CRG UZ BrusselUnknownDiabetic Retinopathy | Cataract | Central Serous Chorioretinopathy
-
Shanghai Pulmonary Hospital, Shanghai, ChinaZunyi Medical College; Ningbo HwaMei Hospital, Zhejiang, China; The First Affiliated...RecruitingLung Adenocarcinoma | Artificial Intelligence | Whole Slide Image | IASLC Grading SystemChina
-
Samsung Medical CenterRecruitingNSCLC | CT | Neoadjuvant ChemoimmunotherapySouth Korea
-
University Hospital, BonnPhilips HealthcareCompletedProstate Cancer | Multiparametric MRIGermany
-
Beijing Tongren HospitalCompleted
-
First Affiliated Hospital of Chongqing Medical...Recruiting
-
Jia LiuCompletedCarotid AtherosclerosisChina
-
M.D. Anderson Cancer CenterActive, not recruitingLiver Metastases | Colorectal Carcinoma | Colon Carcinoma | Diseases of LiverUnited States
-
Philips Healthcare (Suzhou) Co., Ltd.The Second Hospital of Nanjing Medical UniversityNot yet recruitingCT Images
-
Shanghai 10th People's HospitalThird Affiliated Hospital, Sun Yat-Sen UniversityUnknown